EG23757A - Benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmceutical compositions - Google Patents

Benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmceutical compositions

Info

Publication number
EG23757A
EG23757A EG118099A EG118099A EG23757A EG 23757 A EG23757 A EG 23757A EG 118099 A EG118099 A EG 118099A EG 118099 A EG118099 A EG 118099A EG 23757 A EG23757 A EG 23757A
Authority
EG
Egypt
Prior art keywords
preparing
processes
production
advantageous properties
benzoylguanidine derivatives
Prior art date
Application number
EG118099A
Other languages
English (en)
Inventor
Stefan-Matthias Blech
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of EG23757A publication Critical patent/EG23757A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
EG118099A 1998-09-22 1999-09-22 Benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmceutical compositions EG23757A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843489A DE19843489B4 (de) 1998-09-22 1998-09-22 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
EG23757A true EG23757A (en) 2007-08-08

Family

ID=7881872

Family Applications (1)

Application Number Title Priority Date Filing Date
EG118099A EG23757A (en) 1998-09-22 1999-09-22 Benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmceutical compositions

Country Status (35)

Country Link
EP (1) EP1165534B1 (es)
JP (1) JP3817425B2 (es)
KR (1) KR100621821B1 (es)
CN (1) CN1166654C (es)
AR (1) AR023668A1 (es)
AT (1) ATE288425T1 (es)
AU (1) AU764819C (es)
BG (1) BG64985B1 (es)
BR (1) BR9913107A (es)
CA (1) CA2345006C (es)
CO (1) CO5150207A1 (es)
CZ (1) CZ300158B6 (es)
DE (2) DE19843489B4 (es)
EA (1) EA004687B1 (es)
EE (1) EE04749B1 (es)
EG (1) EG23757A (es)
ES (1) ES2237951T3 (es)
HK (1) HK1043367B (es)
HR (1) HRP20010194B1 (es)
HU (1) HU228955B1 (es)
ID (1) ID27759A (es)
IL (1) IL141805A (es)
MY (1) MY121362A (es)
NO (1) NO317993B1 (es)
NZ (1) NZ511167A (es)
PE (1) PE20001085A1 (es)
PL (1) PL195291B1 (es)
PT (1) PT1165534E (es)
RS (1) RS49971B (es)
SA (1) SA99200474B1 (es)
SK (1) SK285578B6 (es)
TR (1) TR200100801T2 (es)
TW (1) TWI221841B (es)
WO (1) WO2000017176A2 (es)
ZA (1) ZA200101212B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730678B2 (en) * 2001-02-15 2004-05-04 Boehringer Ingelheim Pharma Kg Benzoylguanidine salt and hydrates thereof
DE10106970A1 (de) * 2001-02-15 2002-08-29 Boehringer Ingelheim Pharma Neues Benzoylguanidinsalz
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
DE10144030A1 (de) * 2001-09-07 2003-03-27 Boehringer Ingelheim Pharma Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin
FR2871157A1 (fr) * 2004-06-04 2005-12-09 Aventis Pharma Sa Produits biaryl aromatiques, compositions les contenant et utilisation
US20110118262A1 (en) * 2008-07-08 2011-05-19 Boehringer Ingelheim International Gmbh Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601303A1 (de) * 1996-01-16 1997-07-17 Boehringer Ingelheim Kg Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln

Also Published As

Publication number Publication date
HK1043367B (zh) 2005-02-25
HRP20010194A2 (en) 2002-04-30
BG105326A (en) 2001-11-30
RS49971B (sr) 2008-09-29
BR9913107A (pt) 2002-06-11
NO20011428D0 (no) 2001-03-21
ES2237951T3 (es) 2005-08-01
EP1165534A2 (de) 2002-01-02
HUP0200225A3 (en) 2002-12-28
SK285578B6 (sk) 2007-04-05
TWI221841B (en) 2004-10-11
CZ300158B6 (cs) 2009-02-25
AU764819B2 (en) 2003-08-28
ATE288425T1 (de) 2005-02-15
CN1342153A (zh) 2002-03-27
BG64985B1 (bg) 2006-11-30
YU21501A (sh) 2004-03-12
WO2000017176A3 (de) 2001-10-11
PE20001085A1 (es) 2000-10-25
ID27759A (id) 2001-04-26
CZ20011047A3 (cs) 2001-08-15
MY121362A (en) 2006-01-28
EE200100178A (et) 2002-10-15
PT1165534E (pt) 2005-04-29
AU6465999A (en) 2000-04-10
TR200100801T2 (tr) 2002-04-22
DE19843489B4 (de) 2006-12-21
SA99200474B1 (ar) 2006-06-10
EP1165534B1 (de) 2005-02-02
AU764819C (en) 2004-12-16
JP3817425B2 (ja) 2006-09-06
KR100621821B1 (ko) 2006-09-13
PL195291B1 (pl) 2007-08-31
EA200100317A1 (ru) 2001-10-22
NO317993B1 (no) 2005-01-17
HU228955B1 (en) 2013-07-29
NZ511167A (en) 2003-12-19
NO20011428L (no) 2001-03-21
CA2345006C (en) 2007-11-13
PL347234A1 (en) 2002-03-25
CA2345006A1 (en) 2000-03-30
HUP0200225A2 (en) 2002-06-29
ZA200101212B (en) 2002-10-04
SK3962001A3 (en) 2001-10-08
EE04749B1 (et) 2006-12-15
HRP20010194B1 (en) 2009-05-31
DE19843489A1 (de) 2000-03-23
IL141805A0 (en) 2002-03-10
AR023668A1 (es) 2002-09-04
EA004687B1 (ru) 2004-06-24
JP2002538077A (ja) 2002-11-12
DE59911568D1 (de) 2005-03-10
HK1043367A1 (en) 2002-09-13
CN1166654C (zh) 2004-09-15
IL141805A (en) 2005-12-18
CO5150207A1 (es) 2002-04-29
KR20010079884A (ko) 2001-08-22
WO2000017176A2 (de) 2000-03-30

Similar Documents

Publication Publication Date Title
IL142917A0 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
AU4504699A (en) Metallocene-catalyzed oligodecenes, their production and their use as component in lubricants
HUP0104200A3 (en) 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
HUP0203190A3 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
HUP0201225A2 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agent and process for their preparation
HK1040080A1 (en) Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
PL320414A1 (en) Novel derivatives of xantie, method of obtaining them, pharmaceutic agent, application of such derivatives in production of the pharmaceutic agent and method of obtaining same
IL138702A0 (en) Substituted indolinones, the production thereof and their use as medicaments
PL354533A1 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
HUP0004020A3 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same, and their use as antiallergic agent
PL344255A1 (en) Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
IL139358A0 (en) Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
EG23757A (en) Benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmceutical compositions
HUP9801548A3 (en) Blowing agent powder and process for producing the same
HUP0202842A3 (en) Spherical telithromycin clusters, method for their production and use thereof in the pharmaceutical compositions
HUP0002491A3 (en) Polymer composition, process for producing thereof and its use
AU2940400A (en) Cold-storage material with excellent shape stability and process for producing the same
HK1043385A1 (zh) 具有生態和生物性能的飲料及其製備方法
GB2338712B (en) Anti-fouling compositions, and their use in the polymerisation processes
HUP0104267A3 (en) 1,4-diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiane and 1,4-diaryl-2-fluoro-2-butene compounds
SI1127052T1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
ZA986156B (en) Blowing agent powder and process for producing the same
GB9726677D0 (en) Plymeric composition and their production uses
GB9909669D0 (en) Improvements in or relating to manufacture of glass articles or the like